Assembly Biosciences
ASMB
22 hedge funds and large institutions have $14.1M invested in Assembly Biosciences in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 10 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
58% more capital invested
Capital invested by funds: $8.97M → $14.1M (+$5.16M)
19% less funds holding
Funds holding: 27 → 22 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Top Buyers
| 1 |
VAM
Visium Asset Management
New York
|
+$665K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$611K |
| 3 |
IHM
Iguana Healthcare Management
New York
|
+$370K |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$185K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$161K |
Top Sellers
ASMB Hedge Fund Activity: Q3 2014 in Review
22 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2014, worth a combined $14.1M — up 58% from $8.97M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ASMB and 5 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 8 added.
The largest buyer was Visium Asset Management, adding an estimated $665K. The largest seller was Jane Street, exiting entirely with an estimated $123K sold.
- 22 institutional investors held Assembly Biosciences (ASMB) as of Q3 2014, down from 27 in Q2 2014.
- Funds reported $14.1M of Assembly Biosciences stock for Q3 2014, up 58% quarter-over-quarter.
- 5 funds opened new Assembly Biosciences positions in Q3 2014 and 10 closed out, a net change of -5 holders.
- The largest Assembly Biosciences buyer in Q3 2014 was Visium Asset Management, an estimated $665K added.
- The largest Assembly Biosciences seller in Q3 2014 was Jane Street, an estimated $123K sold.
Based on aggregated 13F filings for Q3 2014.